Serum levels of Cholesterol synthesis/absorption markers in subjects of various diseases.

Serum levels of Cholesterol synthesis/absorption markers in subjects of various diseases. - Study of cholesterol synthesis/absorption markers

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004946

Enrollment

600

Registered

2011-01-25

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal subjects, Diabetes, Hyperlipidemia, Essential hypertension, Metabolic syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: We enroll all subjects who visit to our hospital or Sugimura hospital. Number of normal subject:400 Number of Diabetic patients:50 Number of patients with hyperlipidemia:50 Number of patients with hypertension:50 Number of patients with metabolic syndrome: 50

Exclusion criteria

Exclusion criteria: 1.Subjects with inflammation 2.Subjects with fresh cerebrovascular diseases 3.Subjects with hepatic disorder without fatty liver 4.Subjects with severe respiratory disease or severe heart failure 5.Subjects with alcoholicsm or medicinal intoxication 6.Subjects with psychosis 7.Subjects who doctors judge as unfitness

Design outcomes

Primary

Measure	Time frame
1: Calculation of mean value of cholesterol synthesis/absorption markers. 2: Comparison of serum level of cholesterol synthesis/absorption markers between normal subjects and patients with diabetes, hyperlipidemia, hypertension or metabolic syndrome.	—

Secondary

Measure	Time frame
Comparison between cholesterol synthesis/absorption markers and TC, HDL-C, LDL-C, TG, FBG or HbA1.	—

Countries

Japan

Outcome results